Market Tracker

09/22 6:05pm ET

NewLink Genetics Corp (NASDAQ:NLNK)

24.56
Data as of Sep 22
 -1.01 / -3.95%
Today’s Change
16.00
Today|||52-Week Range
53.48
+11.59%
Year-to-Date

Today’s Trading

Previous close25.57
Today’s open25.46
Day’s range23.52 - 25.56
Volume434,851
Average volume (3 months)357,533
Market cap$713.6M
Dividend yield--
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-25.37%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book11.65

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-0.57-2.11%
ENTAEnanta Pharmaceutica...-0.71-1.80%
INFIInfinity Pharmaceuti...-0.21-1.51%
MACKMerrimack Pharmaceut...-0.12-1.65%
Data as of 3:59pm ET, 09/22/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts